b

biote Corp
NASDAQ:BTMD

Watchlist Manager
biote Corp
NASDAQ:BTMD
Watchlist
Price: 6.57 USD -2.23%
Market Cap: 356.2m USD
Have any thoughts about
biote Corp?
Write Note

biote Corp
Stock-Based Compensation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

biote Corp
Stock-Based Compensation Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Stock-Based Compensation Analysis
Latest Figures & CAGR of Competitors

Company Stock-Based Compensation CAGR 3Y CAGR 5Y CAGR 10Y
b
biote Corp
NASDAQ:BTMD
Stock-Based Compensation
$9.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bristol-Myers Squibb Co
NYSE:BMY
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pfizer Inc
NYSE:PFE
Stock-Based Compensation
$698m
CAGR 3-Years
-11%
CAGR 5-Years
0%
CAGR 10-Years
3%
Merck & Co Inc
NYSE:MRK
Stock-Based Compensation
$741m
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
10%
Eli Lilly and Co
NYSE:LLY
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is biote Corp's Stock-Based Compensation?
Stock-Based Compensation
9.1m USD

Based on the financial report for Dec 31, 2023, biote Corp's Stock-Based Compensation amounts to 9.1m USD.

What is biote Corp's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 1Y
-89%

Over the last year, the Stock-Based Compensation growth was -89%.

Back to Top